Helen Mertens

Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition

Janet R. Vos, Ingrid E. Fakkert, Joanne A. de Hullu et al. · JNCI Journal of the National Cancer Institute · 2019 · 69 citations · Full text

Medicine, Genetics, Oncology +17

Simple Rules, Not So Simple: The Use of International Ovarian Tumor Analysis (IOTA) Terminology and Simple Rules in Inexperienced Hands in a Prospective Multicenter Cohort Study

Evelyne M. J. Meys, Iris J.G. Rutten, Roy F.P.M. Kruitwagen et al. · Ultraschall in der Medizin - European Journal of Ultrasound · 2017 · 25 citations · Full text

Medicine, Gynecology, Oncology +17

Quantifying the Resilience of a Healthcare System: Entropy and Network Science Perspectives

Désirée Klemann, Windi Winasti, Fleur Tournois et al. · Entropy · 2023 · 14 citations · Full text

Nursing, Health Systems, Health Systems Evaluation +13

Table 0; documenting the steps to go from clinical database to research dataset

Jip W T M de Kok, Bas C. T. van Bussel, Ronny M. Schnabel et al. · Journal of Clinical Epidemiology · 2024 · 13 citations · Full text

Computing, Biomedical Informatics, Health Informatics +14

Investigating the performance and cost-effectiveness of the simple ultrasound-based rules compared to the risk of malignancy index in the diagnosis of ovarian cancer (SUBSONiC-study): protocol of a prospective multicenter cohort study in the Netherlands

Evelyne M. J. Meys, Iris J.G. Rutten, Roy F.P.M. Kruitwagen et al. · BMC Cancer · 2015 · 12 citations · Full text

Medicine, Gynecology, Oncology +17